Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

462
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
462
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

8.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
8.2K
Cholinesterases: Distribution and Function01:22

Cholinesterases: Distribution and Function

1.2K
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
1.2K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.8K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.8K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

269
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
269
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

851
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
851

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conventional HDL Subclass Measurements Mask Thyroid Hormone-dependent Remodeling Activity Sites in Hypothyroid Individuals.

Journal of the Endocrine Society·2024
Same author

LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans.

Lipids in health and disease·2018
Same author

Letter to the Editor: Getting to the True Values of Thyroglobulin and Anti-Thyroglobulin Antibodies.

The Journal of clinical endocrinology and metabolism·2016
Same author

Diabetes knowledge in young adults: associations with hemoglobin A1C.

Families, systems & health : the journal of collaborative family healthcare·2015
Same author

A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.

Transplantation·2014
Same author

The role of retinoids in the induction of nerve growth factor: a potential treatment for diabetic neuropathy.

Translational research : the journal of laboratory and clinical medicine·2014

Related Experiment Video

Updated: Mar 19, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.8K

Probucol normalizes cholesteryl ester transfer in type 2 diabetes.

John D Bagdade1, James T Lane2, P V Subbaiah3

  • 1Rush University Medical Center, 1725 West Harrison, Chicago, IL 60612, United States.

Diabetes Research and Clinical Practice
|June 21, 2016
PubMed
Summary
This summary is machine-generated.

Probucol treatment normalized cholesteryl ester transfer (CET) in type 2 diabetes (T2D) patients, reducing atherogenic lipoproteins. This suggests probucol

Keywords:
CETPCholesteryl ester transferProbucolType 2 diabetes

More Related Videos

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

4.5K
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.5K

Related Experiment Videos

Last Updated: Mar 19, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.8K
Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

4.5K
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.5K

Area of Science:

  • Lipid metabolism and cardiovascular disease research.
  • Pharmacological interventions for type 2 diabetes complications.

Background:

  • Accelerated cholesteryl ester transfer (CET) protein (CETP) activity is linked to macrovascular disease in type 2 diabetes (T2D).
  • This abnormality, previously observed in type 1 diabetes (T1D) and normalized by probucol, was unstudied in T2D.
  • Understanding CETP's role in T2D is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the effects of probucol on CET activity in patients with type 2 diabetes (T2D).
  • To determine if probucol can normalize CET and reduce the formation of atherogenic lipoproteins in T2D.

Main Methods:

  • Studied net cholesteryl ester (CE) transfer from HDL to apoB lipoproteins (VLDL+LDL) in plasma from seven T2D patients.
  • Measurements were taken before and after two months of daily probucol treatment (1g/day).
  • Recombination studies were used to identify the underlying cause of CET disturbance.

Main Results:

  • Before probucol treatment, CET was significantly elevated in T2D patients compared to controls.
  • The disturbance was attributed to VLDL dysfunction, not altered HDL or CETP behavior.
  • Probucol treatment normalized CET, lowered plasma cholesterol and HDL-C, without affecting glycemic control.

Conclusions:

  • Probucol normalizes CET in T2D by altering CETP's lipoprotein substrates, likely reducing atherogenic lipoprotein formation.
  • The drug's anti-oxidative and anti-inflammatory properties may offer additional cardiovascular benefits in T2D.
  • Probucol shows potential as a therapeutic agent for lipoprotein remodeling and reducing cardiovascular risk in T2D.